Ripertamab
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Riptylimab for the Treatment of Optic Neuritis and Myelitis Spectrum Diseases (NCT07685678) | Zhongming Qiu | 2026-07-15 |
| Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome (NCT07388810) | Mao Jianhua | 2026-02-01 |
Track Ripertamab automatically
Every clearance here is in the API, with alerts when new ones post.